Medical News

RSS

New study finds link between race and treatment delay in women with breast cancer

At a time when access to prompt treatment might affect survival, a large new study finds that African-American and Hispanic women newly diagnosed with breast cancer often face delays in care of more than a month.

1 Feb 2011

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that it has received approval from Health Canada for the Acculis Accu2i percutaneous microwave tissue ablation system for the coagulation of soft tissue during surgical procedures.

1 Feb 2011

ACC introduces new chromogenic endotoxin detection system

Associates of Cape Cod, Inc., (ACC) is proud to introduce its NEW CHROMOGENIC ENDOTOXIN DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent and the new-to-market Pyros Kinetix® Flex Incubating Kinetic tube reader. This system offers our customers diverse options for conducting endotoxin testing.

1 Feb 2011

Research sheds new light on venous thromboembolism following liver resections

Patients undergoing liver surgery have long been considered to be at low risk of venous thromboembolism. However, pulmonary embolism has recently emerged as an increasingly frequent and potentially fatal complication following liver resections.

1 Feb 2011

Positive results from NRM8499 phase I clinical study in patients with Alzheimer's disease

BELLUS Health announced today the results of the phase I clinical study for NRM8499, a prodrug of tramiprosate, intended for the treatment of Alzheimer's disease.

1 Feb 2011

Valeant announces binding agreement to acquire PharmaSwiss for euro 350 million

Valeant Pharmaceuticals International, Inc. and PharmaSwiss S.A. announced today that they have signed a binding agreement for Valeant to acquire PharmaSwiss, a privately-owned branded generics and over-the-counter pharmaceutical company based in Zug, Switzerland for euro 350 million.

1 Feb 2011

Mayo Clinic opens new center to deliver optimal health care solutions

Mayo Clinic announced the launch of a new initiative focused on creating new and improved approaches to delivering health care. The Center for the Science of Health Care Delivery will design, implement, measure and disseminate high-value health care best practices with initial focus areas that include wellness and the prediction, prevention, and management of chronic diseases.

1 Feb 2011

$FDA grants Onyx fast track designation for carfilzomib in treatment of relapsed and refractory multiple myeloma$

FDA grants Onyx fast track designation for carfilzomib in treatment of relapsed and refractory multiple myeloma

Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.

1 Feb 2011

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

ImaginAb, and Eurogentec S.A. announce a development collaboration to establish a novel system for producing engineered antibody fragments. The two companies will produce ImaginAb's optimized antibody fragments with Eurogentec's high-performance Pichia pastoris expression system.

1 Feb 2011

Covidien announces limited release of Endo GIA curved tip and black reloads with Tri-Staple technology

Covidien, a leading global provider of healthcare products, today announced that its new Endo GIA curved tip and black reloads with Tri-Staple technology are available in limited release with a full U.S. roll out expected by mid-year.

1 Feb 2011

Florida judge's ruling imminent in health law multi-state legal challenge

A Florida judge could on Monday become the second judge to declare President Barack Obama's health care reform law unconstitutional, in the biggest legal challenge yet to federal authority to enact the law.

1 Feb 2011

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).

1 Feb 2011

Efforts to repeal Medicare advisory board could attract Dem support

This week, a half-dozen House Republicans unveiled a one-paragraph piece of legislation to dismantle the [Independent Payment Advisory Board], well before it ever gets going.

1 Feb 2011

Scientist identifies natural signaling molecule that can prevent Hemophilia A

A scientist from The Scripps Research Institute has identified a new role for a natural signaling molecule in preventing blood clot formation. The molecule could become a target for the development of novel and cost-effective treatments for blood clotting diseases such as Hemophilia A.

1 Feb 2011

New research finding shows strong relationship between gut bacteria and fatty liver

The more we learn about biology, the closer we get to being able to treat disease - and the more complicated our understanding of disease itself becomes. A new research finding showing a strong relationship between complex microbial ecologies in human intestines and the common but serious medical condition known as fatty liver illustrates this paradox.

1 Feb 2011

New study: Swine flu transmission is most intensive between children of same class

Boys predominantly pass on flu to other boys and girls to girls, according to a new study of how swine flu spread in a primary school during the 2009 pandemic, published today in the journal Proceedings of the National Academy of Sciences. The results also suggest that flu transmission is most intensive between children of the same class, but that sitting next to an infected person does not significantly increase a child's risk of catching flu.

1 Feb 2011

Abbott receives US regulatory clearance and Japanese approval for TREK Coronary Dilatation Catheters

Abbott today announced it has received regulatory clearance in the United States and approval in Japan for its TREK and MINI-TREK Coronary Dilatation Catheters for the treatment of coronary artery disease. The TREK system is used in angioplasty procedures and is designed to enable interventional cardiologists to open patients' narrowed coronary arteries. The TREK system received CE Mark and was launched in Europe in May 2010.

1 Feb 2011

FDA approves Boston Scientific's Renegade HI-FLO Fathom Pre-Loaded System

Boston Scientific Corporation today announced that the U.S. Food and Drug Administration has approved its Renegade HI-FLO Fathom Pre-Loaded System for selective access and delivery of diagnostic, embolic and therapeutic materials into the peripheral vasculature.

1 Feb 2011

Parker Tennessee accepts to purchase common stock of King Pharmaceuticals at $14.25 per share

Pfizer Inc. today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has accepted for purchase all of the shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. at a purchase price of $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.

1 Feb 2011

MRI T2 can determine iron overload in beta-thalassemic patients

Iron overload is a common and serious problem in thalassemic major patients. As iron accumulation is toxic in the body's tissues, accurate estimation of iron stores is of great importance in these patients to prevent iron overload by an appropriate iron chelating therapy.

1 Feb 2011

Medical News

New study finds link between race and treatment delay in women with breast cancer

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

ACC introduces new chromogenic endotoxin detection system

Research sheds new light on venous thromboembolism following liver resections

Positive results from NRM8499 phase I clinical study in patients with Alzheimer's disease

Valeant announces binding agreement to acquire PharmaSwiss for euro 350 million

Mayo Clinic opens new center to deliver optimal health care solutions

FDA grants Onyx fast track designation for carfilzomib in treatment of relapsed and refractory multiple myeloma

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

Covidien announces limited release of Endo GIA curved tip and black reloads with Tri-Staple technology

Florida judge's ruling imminent in health law multi-state legal challenge

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

Efforts to repeal Medicare advisory board could attract Dem support

Scientist identifies natural signaling molecule that can prevent Hemophilia A

New research finding shows strong relationship between gut bacteria and fatty liver

New study: Swine flu transmission is most intensive between children of same class

Abbott receives US regulatory clearance and Japanese approval for TREK Coronary Dilatation Catheters

FDA approves Boston Scientific's Renegade HI-FLO Fathom Pre-Loaded System

Parker Tennessee accepts to purchase common stock of King Pharmaceuticals at $14.25 per share

MRI T2 can determine iron overload in beta-thalassemic patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News